These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Circulating tumor cells: detection, molecular profiling and future prospects. Jacob K, Sollier C, Jabado N. Expert Rev Proteomics; 2007 Dec; 4(6):741-56. PubMed ID: 18067413 [Abstract] [Full Text] [Related]
3. Circulating tumor cells (CTC) detection: clinical impact and future directions. Paterlini-Brechot P, Benali NL. Cancer Lett; 2007 Aug 18; 253(2):180-204. PubMed ID: 17314005 [Abstract] [Full Text] [Related]
4. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Riethdorf S, Pantel K. Pathobiology; 2008 Aug 18; 75(2):140-8. PubMed ID: 18544969 [Abstract] [Full Text] [Related]
8. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications. Danova M, Torchio M, Mazzini G. Expert Rev Mol Diagn; 2011 Jun 18; 11(5):473-85. PubMed ID: 21707456 [Abstract] [Full Text] [Related]
9. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M. J Clin Oncol; 2009 Jul 10; 27(20):3303-11. PubMed ID: 19451443 [Abstract] [Full Text] [Related]
10. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer. Budd GT. Mol Pharm; 2009 Jul 10; 6(5):1307-10. PubMed ID: 19634916 [Abstract] [Full Text] [Related]
12. Circulating tumor cells and bone marrow micrometastasis. Alix-Panabières C, Riethdorf S, Pantel K. Clin Cancer Res; 2008 Aug 15; 14(16):5013-21. PubMed ID: 18698019 [Abstract] [Full Text] [Related]
13. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model. Helzer KT, Barnes HE, Day L, Harvey J, Billings PR, Forsyth A. Cancer Res; 2009 Oct 01; 69(19):7860-6. PubMed ID: 19789350 [Abstract] [Full Text] [Related]
14. Essentials of circulating tumor cells for clinical research and practice. Liberko M, Kolostova K, Bobek V. Crit Rev Oncol Hematol; 2013 Nov 01; 88(2):338-56. PubMed ID: 23830807 [Abstract] [Full Text] [Related]
15. Circulating tumour cell detection on its way to routine diagnostic implementation? Sleijfer S, Gratama JW, Sieuwerts AM, Kraan J, Martens JW, Foekens JA. Eur J Cancer; 2007 Dec 01; 43(18):2645-50. PubMed ID: 17977713 [Abstract] [Full Text] [Related]
17. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Schwarzenbach H, Alix-Panabières C, Müller I, Letang N, Vendrell JP, Rebillard X, Pantel K. Clin Cancer Res; 2009 Feb 01; 15(3):1032-8. PubMed ID: 19188176 [Abstract] [Full Text] [Related]
18. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients. Wong NS, Kahn HJ, Zhang L, Oldfield S, Yang LY, Marks A, Trudeau ME. Breast Cancer Res Treat; 2006 Sep 01; 99(1):63-9. PubMed ID: 16541316 [Abstract] [Full Text] [Related]
19. New technologies for the detection of circulating tumour cells. Gerges N, Rak J, Jabado N. Br Med Bull; 2010 Sep 01; 94():49-64. PubMed ID: 20418405 [Abstract] [Full Text] [Related]
20. Circulating tumor cells as promising novel biomarkers in solid cancers. Lianidou ES, Strati A, Markou A. Crit Rev Clin Lab Sci; 2014 Jun 01; 51(3):160-71. PubMed ID: 24641350 [Abstract] [Full Text] [Related] Page: [Next] [New Search]